← Back to Search

Procedure

Evaluation of Second Esmarch Application on Intravenous Regional Anesthesia Effectiveness

N/A
Waitlist Available
Led By Tolga Turker, MD
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up this outcome measure will only be measured for the duration of the surgical procedure.
Awards & highlights
No Placebo-Only Group

Summary

Intravenous regional anesthesia is a commonly used technique in the outpatient setting for short hand and upper extremity cases, such as carpal tunnel release or trigger finger release. The technique requires a tourniquet, Esmarch bandage, an intravenous line, and lidocaine. It can be performed and learned easily. The technique is safe and easy to perform, and it provides adequate anesthesia for short cases; however, there are still some cases in which adequate anesthesia is not achieved. One of the possible reasons for failure is that the local anesthetic (lidocaine) does not properly exit the veins to reach the interstitial space (where many nerves are located) to provide the nerve block. In this study, the investigators hypothesize that after application of lidocaine to the intravenous system, application of external pressure through the skin will facilitate tissue penetration and improve the block. The only research procedure being done is a re-application of the Esmarch bandage; all other procedures are Standard of Care.

Eligible Conditions
  • Hand Injuries and Disorders
  • Local Anesthesia
  • Upper Extremity Injuries

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~this outcome measure will only be measured for the duration of the surgical procedure.
This trial's timeline: 3 weeks for screening, Varies for treatment, and this outcome measure will only be measured for the duration of the surgical procedure. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
IVRA Block Success Rate

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Esmarch Reapplication GroupExperimental Treatment1 Intervention
Patients in this group will have all the standard intravenous regional anesthesia (IVRA) procedures performed before the start of their surgery with one exception: After standard intravenous regional anesthesia (IVRA) is performed, The elastic Esmarch bandage will be reapplied again on the same arm then will be released. then the surgery will be initiated. the only difference between groups is that the Esmarch reapplied group will be applied the esmach two times. First time, at the standard standard intravenous regional anesthesia (IVRA) before the lidocaine injection and second time, after the injection is completed.
Group II: Control GroupActive Control1 Intervention
Patients in this group will have standard intravenous regional anesthesia (IVRA) performed before the start of their surgery.

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor
536 Previous Clinical Trials
159,617 Total Patients Enrolled
Tolga Turker, MDPrincipal InvestigatorUniversity of Arizona
1 Previous Clinical Trials
1,000 Total Patients Enrolled
~10 spots leftby Dec 2025